Pharmaceutical Executive July 29, 2021
Michael Wong

In this installment of the Harvard Business School Healthcare Alumni Association (HBSHAA) Q&A series, Leslie Donato, EVP and Chief Strategy Officer at AmerisourceBergen, talks to Michael Wong about converting innovative ideas into revenue-generating platforms.

Michael Wong: When most people think about the “Main Line” neighborhoods that are west of Philadelphia, images that pop up are likely of premier colleges nestled in leafy neighborhoods,1 versus a company that was ranked 8th on the most recent Fortune 500 company list.2 As several Fortune 500 investor presentations have the inevitable reference to “innovation”, what is the password for success behind your firm’s ability to convert innovative ideas into revenue-generating platforms?

Leslie Donato: At our core, AmerisourceBergen is a purpose-driven organization where we are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Trends
Related Articles:
Methods To Alter Cellular Gene Expression
Pfizer beats revenue estimates, raises profit outlook on cost cuts and smaller-than-feared drop in Covid drug sales
Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
The Time Is Now For Federal Reform Of Direct-To-Consumer Advertising Of Prescription Drugs
Pharmacy Industry Pushes Pharmacist Prescribing As Specialty Drugs Emerge

Share This Article